Accumulating evidence reveals that IL-17 + FOXP3+ T cells are shown highly in colon [152] and esophageal [153] cancers, inflammatory bowel disease [154], periodontitis [155], and rheumatoid arthritis [156]. The gene discussed is FOXP3; the disease is cancer.